Among the 34 NSCLC cell lines that were examined, 10 cell lines harbored an EGFR mutation (EGFR-mut), 7 cell lines harbored a KRAS mutation (KRAS-mut), 4 cell lines harbored a BRAF mutation (BRAF-mut), 1 cell line harbored a HER2 mutation (HER2-mut), 1 cell line harbored an NRAS mutation (NRAS-mut), and 11 cell lines harbored none of these mutations (Supplementary Table S1). Here, KRAS is linked to non-small cell lung carcinoma.